Apigenin has been reported to sensitize non-small cell lung cancer (NSCLC) cell lines A549 and H1299 to TRAIL-induced apoptosis through the c-Jun N-terminal kinase-mediated p53-dependent upregulation of DR4 and DR5 [41]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.